Profile
Sector:
HealthcareIndustry:
Medical DevicesCountry:
United StatesIPO:
02 November 2020Website:
http://www.invobio.comNext earnings report:
14 August 2024Last dividends:
N/ANext dividends:
N/APrice
after hours | 6 min agoDividend
Analysts recommendations
Institutional Ownership
INVO Latest News
Invo Bioscience (NASDAQ: INVO) stock is surging today after the company released its earnings report for the fourth quarter of 2023, which showed a $2 million net loss for the healthcare services fertility company.
One of the most impressive movers making the most noise in today's session has to be INVO Bioscience (NASDAQ: INVO ). Shares of INVO stock have more than tripled in today's session, surging well more than 325% at the time of writing.
INVO Bioscience, Inc. (NASDAQ:INVO ) Q2 2023 Earnings Conference Call August 14, 2023 4:30 PM ET Company Participants Robert Blum - Investor Relations Steve Shum - Chief Executive Officer Mike Campbell - Chief Operating and Vice President, Business Development Andrea Goren - Chief Financial Officer Operator Good afternoon. And welcome, to the INVO Bioscience Second Quarter Fiscal Year 2023 Financial Results Conference Call.
INVO Bioscience (NASDAQ: INVO ) stock is on the rise Monday after the company announced a public share offering on Friday. According to a Securities and Exchange Commission (SEC) filing from INVO Bioscience, certain investors may offer up to 6,241,493 shares of INVO stock.
INVO Bioscience, Inc. (NASDAQ:INVO ) Q1 2023 Results Conference Call May 15, 2023 4:30 PM ET Company Participants Robert Blum - Lytham Partners Steve Shum - CEO Mike Campbell - Chief Operating Officer and VP of Business Development Andrea Goren - Chief Financial Officer Conference Call Participants Joanne Lee - Maxim Group Rodney Baber - Paulson Investments Operator Good day. And welcome to the INVO First Quarter 2023 Financial Results Conference Call.
INVO Bioscience, Inc. (NASDAQ:INVO) Q4 2022 Earnings Conference Call April 17, 2023 4:30 PM ET
INVO Bioscience announced that it has entered into a securities purchase agreement with a single healthcare-focused institutional investor to buy 3,680,000 shares of common stock. The post INVO Bioscience Announces Pricing of $3 Million Registered Direct Offering Priced At-The-Market appeared first on Pulse 2.0.
What type of business is INVO Bioscience?
INVO Bioscience, Inc., a commercial-stage fertility company, provides assisted reproductive technology solutions worldwide. Its flagship product is the INVOcell, a medical device that allows fertilization and early embryo development to take place in vivo within the woman's body. The company was founded in 2007 and is based in Sarasota, Florida.
What sector is INVO Bioscience in?
INVO Bioscience is in the Healthcare sector
What industry is INVO Bioscience in?
INVO Bioscience is in the Medical Devices industry
What country is INVO Bioscience from?
INVO Bioscience is headquartered in United States
When did INVO Bioscience go public?
INVO Bioscience initial public offering (IPO) was on 02 November 2020
What is INVO Bioscience website?
https://www.invobio.com
Is INVO Bioscience in the S&P 500?
No, INVO Bioscience is not included in the S&P 500 index
Is INVO Bioscience in the NASDAQ 100?
No, INVO Bioscience is not included in the NASDAQ 100 index
Is INVO Bioscience in the Dow Jones?
No, INVO Bioscience is not included in the Dow Jones index
When does INVO Bioscience report earnings?
The next expected earnings date for INVO Bioscience is 14 August 2024